HEM Insider Trading Activity and SEC Form 4 Filings
HEM insider trading summary
No open-market insider purchases or sales of Hemosense Inc (HEM) have been reported on SEC Form 4 in the past 12 months.
Latest HEM insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Sep 13, 2007 | Mpm Asset Management Investors 2000b LLC | 10% Owner | Sell | $2.2M (174,800 @ $12.79) |
| Sep 13, 2007 | Michael Steinmetz | 10% Owner | Sell | $2.2M (174,800 @ $12.79) |
| Sep 13, 2007 | Mpm Asset Management II LLC | 10% Owner | Sell | $2.2M (174,800 @ $12.79) |
| Sep 13, 2007 | Mpm Bioventures Gmbh & Co Parallel Beteiligungs Kg | 10% Owner | Sell | $2.2M (174,800 @ $12.79) |
| Sep 13, 2007 | Mpm Asset Management II LP | 10% Owner | Sell | $2.2M (174,800 @ $12.79) |
| Sep 13, 2007 | Ansbert Gadicke | 10% Owner | Sell | $2.2M (174,800 @ $12.79) |
| Sep 13, 2007 | Mpm Bioventures II LP | 10% Owner | Sell | $2.2M (174,800 @ $12.79) |
| Sep 13, 2007 | Kurt Wheeler | Director | Sell | $2.2M (174,800 @ $12.79) |
| Sep 13, 2007 | Mpm Bioventures II Qp LP | 10% Owner | Sell | $2.2M (174,800 @ $12.79) |
| Sep 13, 2007 | Nicholas Galakatos | 10% Owner | Sell | $2.2M (174,800 @ $12.79) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.